23 June 2020
The ECHA Member State Committee has not accepted to identify resorcinol as an SVHC substance due to its endocrine disrupting properties.
The Member State Committee has not unanimously supported France's proposal to identify resorcinol (EC 203-585-2; CAS 108-46-3) as SVHC. However, the committee acknowledged the existence of scientific evidence that resorcinol is an endocrine disruptor as defined by the World Health Organization (WHO).
After receiving the MSC's opinion, the Commission has three months to prepare a draft proposal on identification as SVHC and will therefore take a final decision in its committee procedure.
Resorcinol is used to produce rubber compounds, resins and coatings, as well as cosmetics. It is the first substance proposed as SVHC because of its harmful effects on the thyroid in humans. The majority of the committee members concluded that there is scientific evidence of likely serious effects on human health due to hypothyroidism and potential effects on neurological development during pregnancy. However, some members expressed different opinions that the substance presents an equivalent level of concern.
For more information visit the ECHA website.
23 September 2020
Regulation (EU) N ° 2020/1149 has been published which amends Annex XVII of Regulation (EC) N ° 1907/2006 (REACH). The update concerns a ban on placing on the market for diisocyanates unless certain...
20 August 2020
Greece has proposed a new harmonized classification for ethanol CAS 64-17-5. The proposed classification is as follows: Flam. Liq. 2, H225 Eye Irrit. 2, H319 Repr. 2, H361d Lact., H362 STOT SE 3, H336...